nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprostone—PTGER4—hematologic cancer	0.252	0.738	CbGaD
Dinoprostone—SLC22A1—hematologic cancer	0.0894	0.262	CbGaD
Dinoprostone—ABCC4—Tioguanine—hematologic cancer	0.0369	0.097	CbGbCtD
Dinoprostone—ABCC5—Mercaptopurine—hematologic cancer	0.0319	0.0838	CbGbCtD
Dinoprostone—SLCO1A2—Chlorambucil—hematologic cancer	0.0201	0.0527	CbGbCtD
Dinoprostone—SLCO3A1—Methotrexate—hematologic cancer	0.0163	0.0429	CbGbCtD
Dinoprostone—ABCC5—Cisplatin—hematologic cancer	0.0161	0.0422	CbGbCtD
Dinoprostone—ABCC4—Mercaptopurine—hematologic cancer	0.0153	0.0403	CbGbCtD
Dinoprostone—SLC22A2—Daunorubicin—hematologic cancer	0.0144	0.0379	CbGbCtD
Dinoprostone—SLC22A2—Cytarabine—hematologic cancer	0.0127	0.0334	CbGbCtD
Dinoprostone—CYP11A1—Dexamethasone—hematologic cancer	0.0123	0.0323	CbGbCtD
Dinoprostone—SLC22A2—Cladribine—hematologic cancer	0.012	0.0316	CbGbCtD
Dinoprostone—SLC22A1—Cytarabine—hematologic cancer	0.011	0.029	CbGbCtD
Dinoprostone—SLC22A2—Imatinib—hematologic cancer	0.011	0.029	CbGbCtD
Dinoprostone—CYP1A2—Anagrelide—hematologic cancer	0.0108	0.0284	CbGbCtD
Dinoprostone—SLC22A1—Cladribine—hematologic cancer	0.0104	0.0274	CbGbCtD
Dinoprostone—SLCO1C1—Methotrexate—hematologic cancer	0.0104	0.0274	CbGbCtD
Dinoprostone—CYP19A1—Betamethasone—hematologic cancer	0.00983	0.0258	CbGbCtD
Dinoprostone—SLC22A1—Imatinib—hematologic cancer	0.00959	0.0252	CbGbCtD
Dinoprostone—SLC22A8—Mercaptopurine—hematologic cancer	0.00957	0.0252	CbGbCtD
Dinoprostone—PTGFR—ovarian follicle—hematologic cancer	0.00759	0.127	CbGeAlD
Dinoprostone—SLCO1A2—Prednisolone—hematologic cancer	0.00759	0.0199	CbGbCtD
Dinoprostone—SLCO1A2—Prednisone—hematologic cancer	0.00716	0.0188	CbGbCtD
Dinoprostone—SLCO1B1—Irinotecan—hematologic cancer	0.00641	0.0168	CbGbCtD
Dinoprostone—SLC22A2—Vinblastine—hematologic cancer	0.00613	0.0161	CbGbCtD
Dinoprostone—CYP11A1—ovarian follicle—hematologic cancer	0.00579	0.0972	CbGeAlD
Dinoprostone—CYP19A1—Dexamethasone—hematologic cancer	0.00572	0.015	CbGbCtD
Dinoprostone—CYP1A2—Carmustine—hematologic cancer	0.00567	0.0149	CbGbCtD
Dinoprostone—SLC22A2—Cisplatin—hematologic cancer	0.00562	0.0148	CbGbCtD
Dinoprostone—SLC22A11—Methotrexate—hematologic cancer	0.00538	0.0141	CbGbCtD
Dinoprostone—SLC22A7—Methotrexate—hematologic cancer	0.00513	0.0135	CbGbCtD
Dinoprostone—ABCC4—Methotrexate—hematologic cancer	0.00501	0.0132	CbGbCtD
Dinoprostone—CYP1A2—Methoxsalen—hematologic cancer	0.00482	0.0127	CbGbCtD
Dinoprostone—CYP1A2—Bortezomib—hematologic cancer	0.00459	0.0121	CbGbCtD
Dinoprostone—SLCO1A2—Dexamethasone—hematologic cancer	0.00447	0.0118	CbGbCtD
Dinoprostone—CYP1A2—Daunorubicin—hematologic cancer	0.00439	0.0115	CbGbCtD
Dinoprostone—CYP1A2—Alitretinoin—hematologic cancer	0.0043	0.0113	CbGbCtD
Dinoprostone—CYP1A2—Thalidomide—hematologic cancer	0.004	0.0105	CbGbCtD
Dinoprostone—CYP19A1—ovarian follicle—hematologic cancer	0.00376	0.0631	CbGeAlD
Dinoprostone—SLCO1A2—Methotrexate—hematologic cancer	0.00359	0.00945	CbGbCtD
Dinoprostone—CYP1A2—Dacarbazine—hematologic cancer	0.00344	0.00903	CbGbCtD
Dinoprostone—SLCO1B1—Methotrexate—hematologic cancer	0.00339	0.00891	CbGbCtD
Dinoprostone—CYP1A2—Imatinib—hematologic cancer	0.00336	0.00883	CbGbCtD
Dinoprostone—SLC22A8—Methotrexate—hematologic cancer	0.00313	0.00823	CbGbCtD
Dinoprostone—CYP1A2—Dasatinib—hematologic cancer	0.0027	0.00709	CbGbCtD
Dinoprostone—SLC22A6—Methotrexate—hematologic cancer	0.00218	0.00573	CbGbCtD
Dinoprostone—Misoprostol—PTGER4—hematologic cancer	0.00202	1	CrCbGaD
Dinoprostone—CYP1A2—Etoposide—hematologic cancer	0.00168	0.00442	CbGbCtD
Dinoprostone—PTGER4—hematopoietic system—hematologic cancer	0.00135	0.0227	CbGeAlD
Dinoprostone—SLC51B—lung—hematologic cancer	0.00108	0.0181	CbGeAlD
Dinoprostone—SLC51B—testis—hematologic cancer	0.00102	0.0171	CbGeAlD
Dinoprostone—SLC51A—gonad—hematologic cancer	0.00101	0.017	CbGeAlD
Dinoprostone—HPGDS—hematopoietic system—hematologic cancer	0.000991	0.0166	CbGeAlD
Dinoprostone—PTGER2—blood—hematologic cancer	0.000914	0.0153	CbGeAlD
Dinoprostone—PTGER4—blood—hematologic cancer	0.000897	0.0151	CbGeAlD
Dinoprostone—PTGER2—bone marrow—hematologic cancer	0.000884	0.0148	CbGeAlD
Dinoprostone—SLC51A—blood—hematologic cancer	0.000881	0.0148	CbGeAlD
Dinoprostone—PTGIR—hematopoietic system—hematologic cancer	0.000808	0.0136	CbGeAlD
Dinoprostone—PTGER2—lung—hematologic cancer	0.000801	0.0134	CbGeAlD
Dinoprostone—PTGER4—lung—hematologic cancer	0.000786	0.0132	CbGeAlD
Dinoprostone—SLC51A—lung—hematologic cancer	0.000772	0.013	CbGeAlD
Dinoprostone—PTGER2—testis—hematologic cancer	0.000756	0.0127	CbGeAlD
Dinoprostone—HPGDS—gonad—hematologic cancer	0.000753	0.0126	CbGeAlD
Dinoprostone—PTGER4—testis—hematologic cancer	0.000742	0.0125	CbGeAlD
Dinoprostone—SLC51A—testis—hematologic cancer	0.000729	0.0122	CbGeAlD
Dinoprostone—CYP11A1—hematopoietic system—hematologic cancer	0.000698	0.0117	CbGeAlD
Dinoprostone—PTGER3—lung—hematologic cancer	0.000666	0.0112	CbGeAlD
Dinoprostone—HPGDS—blood—hematologic cancer	0.000656	0.011	CbGeAlD
Dinoprostone—HPGDS—bone marrow—hematologic cancer	0.000635	0.0107	CbGeAlD
Dinoprostone—PTGER3—testis—hematologic cancer	0.000628	0.0105	CbGeAlD
Dinoprostone—PTGIR—gonad—hematologic cancer	0.000614	0.0103	CbGeAlD
Dinoprostone—HPGDS—lung—hematologic cancer	0.000575	0.00966	CbGeAlD
Dinoprostone—SLCO1B1—hematopoietic system—hematologic cancer	0.000571	0.0096	CbGeAlD
Dinoprostone—PTGER2—lymph node—hematologic cancer	0.000548	0.0092	CbGeAlD
Dinoprostone—HPGDS—testis—hematologic cancer	0.000543	0.00912	CbGeAlD
Dinoprostone—SLCO3A1—gonad—hematologic cancer	0.000542	0.0091	CbGeAlD
Dinoprostone—PTGER4—lymph node—hematologic cancer	0.000538	0.00903	CbGeAlD
Dinoprostone—PTGIR—blood—hematologic cancer	0.000535	0.00899	CbGeAlD
Dinoprostone—PTGFR—lung—hematologic cancer	0.000532	0.00894	CbGeAlD
Dinoprostone—CYP11A1—gonad—hematologic cancer	0.000531	0.00892	CbGeAlD
Dinoprostone—SLC51A—lymph node—hematologic cancer	0.000528	0.00887	CbGeAlD
Dinoprostone—SLCO2B1—hematopoietic system—hematologic cancer	0.000505	0.00849	CbGeAlD
Dinoprostone—PTGFR—testis—hematologic cancer	0.000502	0.00843	CbGeAlD
Dinoprostone—SLCO3A1—blood—hematologic cancer	0.000472	0.00793	CbGeAlD
Dinoprostone—PTGIR—lung—hematologic cancer	0.000469	0.00788	CbGeAlD
Dinoprostone—SLCO1A2—hematopoietic system—hematologic cancer	0.000465	0.00781	CbGeAlD
Dinoprostone—CYP11A1—blood—hematologic cancer	0.000463	0.00777	CbGeAlD
Dinoprostone—PTGER3—lymph node—hematologic cancer	0.000455	0.00765	CbGeAlD
Dinoprostone—CYP19A1—hematopoietic system—hematologic cancer	0.000454	0.00762	CbGeAlD
Dinoprostone—ABCC4—hematopoietic system—hematologic cancer	0.000447	0.00752	CbGeAlD
Dinoprostone—SLCO1C1—testis—hematologic cancer	0.000444	0.00746	CbGeAlD
Dinoprostone—SLC22A8—hematopoietic system—hematologic cancer	0.000444	0.00746	CbGeAlD
Dinoprostone—PTGIR—testis—hematologic cancer	0.000443	0.00743	CbGeAlD
Dinoprostone—SLC22A7—testis—hematologic cancer	0.000421	0.00707	CbGeAlD
Dinoprostone—SLCO3A1—lung—hematologic cancer	0.000414	0.00695	CbGeAlD
Dinoprostone—ABCC5—bone marrow—hematologic cancer	0.000414	0.00695	CbGeAlD
Dinoprostone—SLCO2A1—lung—hematologic cancer	0.00041	0.00689	CbGeAlD
Dinoprostone—HPGDS—lymph node—hematologic cancer	0.000394	0.00661	CbGeAlD
Dinoprostone—SLCO3A1—testis—hematologic cancer	0.000391	0.00656	CbGeAlD
Dinoprostone—SLCO2A1—testis—hematologic cancer	0.000387	0.0065	CbGeAlD
Dinoprostone—CYP11A1—testis—hematologic cancer	0.000383	0.00643	CbGeAlD
Dinoprostone—SLCO1B1—blood—hematologic cancer	0.000379	0.00636	CbGeAlD
Dinoprostone—SLCO4A1—lung—hematologic cancer	0.000377	0.00633	CbGeAlD
Dinoprostone—ABCC5—lung—hematologic cancer	0.000375	0.0063	CbGeAlD
Dinoprostone—PTGFR—lymph node—hematologic cancer	0.000364	0.00611	CbGeAlD
Dinoprostone—SLCO4A1—testis—hematologic cancer	0.000356	0.00598	CbGeAlD
Dinoprostone—ABCC5—testis—hematologic cancer	0.000354	0.00594	CbGeAlD
Dinoprostone—CYP19A1—gonad—hematologic cancer	0.000345	0.00579	CbGeAlD
Dinoprostone—SLCO1C1—lymph node—hematologic cancer	0.000322	0.00541	CbGeAlD
Dinoprostone—PTGIR—lymph node—hematologic cancer	0.000321	0.00539	CbGeAlD
Dinoprostone—SLC22A1—blood—hematologic cancer	0.00032	0.00537	CbGeAlD
Dinoprostone—CYP1A2—hematopoietic system—hematologic cancer	0.000304	0.00511	CbGeAlD
Dinoprostone—CYP19A1—blood—hematologic cancer	0.000301	0.00505	CbGeAlD
Dinoprostone—ABCC4—blood—hematologic cancer	0.000296	0.00498	CbGeAlD
Dinoprostone—SLC22A8—blood—hematologic cancer	0.000294	0.00494	CbGeAlD
Dinoprostone—SLCO2B1—lung—hematologic cancer	0.000293	0.00493	CbGeAlD
Dinoprostone—ABCC4—bone marrow—hematologic cancer	0.000287	0.00482	CbGeAlD
Dinoprostone—SLCO3A1—lymph node—hematologic cancer	0.000283	0.00475	CbGeAlD
Dinoprostone—SLCO2A1—lymph node—hematologic cancer	0.00028	0.00471	CbGeAlD
Dinoprostone—CYP11A1—lymph node—hematologic cancer	0.000277	0.00466	CbGeAlD
Dinoprostone—SLCO2B1—testis—hematologic cancer	0.000277	0.00465	CbGeAlD
Dinoprostone—SLCO1A2—lung—hematologic cancer	0.00027	0.00454	CbGeAlD
Dinoprostone—ABCC4—lung—hematologic cancer	0.00026	0.00436	CbGeAlD
Dinoprostone—SLCO4A1—lymph node—hematologic cancer	0.000258	0.00433	CbGeAlD
Dinoprostone—ABCC5—lymph node—hematologic cancer	0.000256	0.00431	CbGeAlD
Dinoprostone—SLCO1A2—testis—hematologic cancer	0.000255	0.00428	CbGeAlD
Dinoprostone—CYP19A1—testis—hematologic cancer	0.000249	0.00418	CbGeAlD
Dinoprostone—ABCC4—testis—hematologic cancer	0.000245	0.00412	CbGeAlD
Dinoprostone—CYP1A2—blood—hematologic cancer	0.000201	0.00338	CbGeAlD
Dinoprostone—SLCO2B1—lymph node—hematologic cancer	0.000201	0.00337	CbGeAlD
Dinoprostone—CYP19A1—lymph node—hematologic cancer	0.00018	0.00303	CbGeAlD
Dinoprostone—ABCC4—lymph node—hematologic cancer	0.000178	0.00299	CbGeAlD
Dinoprostone—CYP1A2—lung—hematologic cancer	0.000177	0.00297	CbGeAlD
Dinoprostone—Headache—Thalidomide—hematologic cancer	3.38e-05	0.000283	CcSEcCtD
Dinoprostone—Pain—Prednisolone—hematologic cancer	3.38e-05	0.000283	CcSEcCtD
Dinoprostone—Asthenia—Gemcitabine—hematologic cancer	3.36e-05	0.000282	CcSEcCtD
Dinoprostone—Dizziness—Ifosfamide—hematologic cancer	3.35e-05	0.000281	CcSEcCtD
Dinoprostone—Pharyngitis—Methotrexate—hematologic cancer	3.35e-05	0.000281	CcSEcCtD
Dinoprostone—Vision blurred—Prednisone—hematologic cancer	3.31e-05	0.000278	CcSEcCtD
Dinoprostone—Nausea—Thiotepa—hematologic cancer	3.31e-05	0.000278	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	3.31e-05	0.000278	CcSEcCtD
Dinoprostone—Anaphylactic shock—Dexamethasone—hematologic cancer	3.29e-05	0.000277	CcSEcCtD
Dinoprostone—Anaphylactic shock—Betamethasone—hematologic cancer	3.29e-05	0.000277	CcSEcCtD
Dinoprostone—Diarrhoea—Irinotecan—hematologic cancer	3.29e-05	0.000276	CcSEcCtD
Dinoprostone—Diarrhoea—Mitoxantrone—hematologic cancer	3.29e-05	0.000276	CcSEcCtD
Dinoprostone—Vomiting—Carmustine—hematologic cancer	3.29e-05	0.000276	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Etoposide—hematologic cancer	3.27e-05	0.000275	CcSEcCtD
Dinoprostone—Dizziness—Vincristine—hematologic cancer	3.27e-05	0.000274	CcSEcCtD
Dinoprostone—Rash—Carmustine—hematologic cancer	3.26e-05	0.000274	CcSEcCtD
Dinoprostone—Dermatitis—Carmustine—hematologic cancer	3.26e-05	0.000274	CcSEcCtD
Dinoprostone—Vomiting—Alitretinoin—hematologic cancer	3.26e-05	0.000274	CcSEcCtD
Dinoprostone—Paraesthesia—Triamcinolone—hematologic cancer	3.26e-05	0.000274	CcSEcCtD
Dinoprostone—Headache—Carmustine—hematologic cancer	3.24e-05	0.000272	CcSEcCtD
Dinoprostone—Shock—Dexamethasone—hematologic cancer	3.24e-05	0.000272	CcSEcCtD
Dinoprostone—Shock—Betamethasone—hematologic cancer	3.24e-05	0.000272	CcSEcCtD
Dinoprostone—Dyspnoea—Triamcinolone—hematologic cancer	3.24e-05	0.000272	CcSEcCtD
Dinoprostone—Rash—Alitretinoin—hematologic cancer	3.23e-05	0.000271	CcSEcCtD
Dinoprostone—Dermatitis—Alitretinoin—hematologic cancer	3.23e-05	0.000271	CcSEcCtD
Dinoprostone—Vomiting—Ifosfamide—hematologic cancer	3.22e-05	0.000271	CcSEcCtD
Dinoprostone—Hypersensitivity—Cisplatin—hematologic cancer	3.22e-05	0.00027	CcSEcCtD
Dinoprostone—Tachycardia—Betamethasone—hematologic cancer	3.22e-05	0.00027	CcSEcCtD
Dinoprostone—Tachycardia—Dexamethasone—hematologic cancer	3.22e-05	0.00027	CcSEcCtD
Dinoprostone—Headache—Alitretinoin—hematologic cancer	3.21e-05	0.00027	CcSEcCtD
Dinoprostone—Diarrhoea—Gemcitabine—hematologic cancer	3.21e-05	0.000269	CcSEcCtD
Dinoprostone—Nausea—Thalidomide—hematologic cancer	3.2e-05	0.000269	CcSEcCtD
Dinoprostone—Rash—Ifosfamide—hematologic cancer	3.2e-05	0.000268	CcSEcCtD
Dinoprostone—Dermatitis—Ifosfamide—hematologic cancer	3.19e-05	0.000268	CcSEcCtD
Dinoprostone—Hyperhidrosis—Dexamethasone—hematologic cancer	3.18e-05	0.000267	CcSEcCtD
Dinoprostone—Hyperhidrosis—Betamethasone—hematologic cancer	3.18e-05	0.000267	CcSEcCtD
Dinoprostone—Dizziness—Irinotecan—hematologic cancer	3.18e-05	0.000267	CcSEcCtD
Dinoprostone—Body temperature increased—Etoposide—hematologic cancer	3.16e-05	0.000266	CcSEcCtD
Dinoprostone—Abdominal pain—Etoposide—hematologic cancer	3.16e-05	0.000266	CcSEcCtD
Dinoprostone—Syncope—Prednisone—hematologic cancer	3.15e-05	0.000265	CcSEcCtD
Dinoprostone—Vomiting—Vincristine—hematologic cancer	3.14e-05	0.000264	CcSEcCtD
Dinoprostone—Asthenia—Cisplatin—hematologic cancer	3.13e-05	0.000263	CcSEcCtD
Dinoprostone—Pharyngitis—Epirubicin—hematologic cancer	3.13e-05	0.000263	CcSEcCtD
Dinoprostone—Rash—Vincristine—hematologic cancer	3.12e-05	0.000262	CcSEcCtD
Dinoprostone—Dermatitis—Vincristine—hematologic cancer	3.11e-05	0.000261	CcSEcCtD
Dinoprostone—Pain—Triamcinolone—hematologic cancer	3.1e-05	0.000261	CcSEcCtD
Dinoprostone—Headache—Vincristine—hematologic cancer	3.1e-05	0.00026	CcSEcCtD
Dinoprostone—Loss of consciousness—Prednisone—hematologic cancer	3.09e-05	0.000259	CcSEcCtD
Dinoprostone—Hypotension—Dexamethasone—hematologic cancer	3.08e-05	0.000258	CcSEcCtD
Dinoprostone—Hypotension—Betamethasone—hematologic cancer	3.08e-05	0.000258	CcSEcCtD
Dinoprostone—Nausea—Carmustine—hematologic cancer	3.07e-05	0.000258	CcSEcCtD
Dinoprostone—Angiopathy—Methotrexate—hematologic cancer	3.06e-05	0.000257	CcSEcCtD
Dinoprostone—Vomiting—Irinotecan—hematologic cancer	3.06e-05	0.000257	CcSEcCtD
Dinoprostone—Vomiting—Mitoxantrone—hematologic cancer	3.06e-05	0.000257	CcSEcCtD
Dinoprostone—Immune system disorder—Methotrexate—hematologic cancer	3.05e-05	0.000256	CcSEcCtD
Dinoprostone—Nausea—Alitretinoin—hematologic cancer	3.05e-05	0.000256	CcSEcCtD
Dinoprostone—Hypertension—Prednisone—hematologic cancer	3.03e-05	0.000255	CcSEcCtD
Dinoprostone—Rash—Irinotecan—hematologic cancer	3.03e-05	0.000255	CcSEcCtD
Dinoprostone—Rash—Mitoxantrone—hematologic cancer	3.03e-05	0.000255	CcSEcCtD
Dinoprostone—Dermatitis—Mitoxantrone—hematologic cancer	3.03e-05	0.000255	CcSEcCtD
Dinoprostone—Dermatitis—Irinotecan—hematologic cancer	3.03e-05	0.000255	CcSEcCtD
Dinoprostone—Chills—Methotrexate—hematologic cancer	3.03e-05	0.000254	CcSEcCtD
Dinoprostone—Headache—Mitoxantrone—hematologic cancer	3.01e-05	0.000253	CcSEcCtD
Dinoprostone—Headache—Irinotecan—hematologic cancer	3.01e-05	0.000253	CcSEcCtD
Dinoprostone—Nausea—Ifosfamide—hematologic cancer	3.01e-05	0.000253	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	3e-05	0.000252	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	3e-05	0.000252	CcSEcCtD
Dinoprostone—Arthralgia—Prednisone—hematologic cancer	2.99e-05	0.000251	CcSEcCtD
Dinoprostone—Myalgia—Prednisone—hematologic cancer	2.99e-05	0.000251	CcSEcCtD
Dinoprostone—Diarrhoea—Cisplatin—hematologic cancer	2.99e-05	0.000251	CcSEcCtD
Dinoprostone—Vomiting—Gemcitabine—hematologic cancer	2.98e-05	0.00025	CcSEcCtD
Dinoprostone—Paraesthesia—Betamethasone—hematologic cancer	2.96e-05	0.000248	CcSEcCtD
Dinoprostone—Paraesthesia—Dexamethasone—hematologic cancer	2.96e-05	0.000248	CcSEcCtD
Dinoprostone—Rash—Gemcitabine—hematologic cancer	2.96e-05	0.000248	CcSEcCtD
Dinoprostone—Dermatitis—Gemcitabine—hematologic cancer	2.95e-05	0.000248	CcSEcCtD
Dinoprostone—Hypersensitivity—Etoposide—hematologic cancer	2.95e-05	0.000248	CcSEcCtD
Dinoprostone—Headache—Gemcitabine—hematologic cancer	2.94e-05	0.000247	CcSEcCtD
Dinoprostone—Nausea—Vincristine—hematologic cancer	2.94e-05	0.000246	CcSEcCtD
Dinoprostone—Flushing—Epirubicin—hematologic cancer	2.93e-05	0.000246	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisolone—hematologic cancer	2.91e-05	0.000244	CcSEcCtD
Dinoprostone—Pharyngitis—Doxorubicin—hematologic cancer	2.9e-05	0.000244	CcSEcCtD
Dinoprostone—Asthenia—Etoposide—hematologic cancer	2.87e-05	0.000241	CcSEcCtD
Dinoprostone—Body temperature increased—Triamcinolone—hematologic cancer	2.87e-05	0.000241	CcSEcCtD
Dinoprostone—Anaphylactic shock—Prednisone—hematologic cancer	2.87e-05	0.000241	CcSEcCtD
Dinoprostone—Angiopathy—Epirubicin—hematologic cancer	2.87e-05	0.000241	CcSEcCtD
Dinoprostone—Nausea—Mitoxantrone—hematologic cancer	2.86e-05	0.00024	CcSEcCtD
Dinoprostone—Nausea—Irinotecan—hematologic cancer	2.86e-05	0.00024	CcSEcCtD
Dinoprostone—Immune system disorder—Epirubicin—hematologic cancer	2.85e-05	0.00024	CcSEcCtD
Dinoprostone—Back pain—Methotrexate—hematologic cancer	2.84e-05	0.000239	CcSEcCtD
Dinoprostone—Chills—Epirubicin—hematologic cancer	2.83e-05	0.000238	CcSEcCtD
Dinoprostone—Shock—Prednisone—hematologic cancer	2.82e-05	0.000237	CcSEcCtD
Dinoprostone—Arrhythmia—Epirubicin—hematologic cancer	2.82e-05	0.000237	CcSEcCtD
Dinoprostone—Pain—Dexamethasone—hematologic cancer	2.82e-05	0.000237	CcSEcCtD
Dinoprostone—Pain—Betamethasone—hematologic cancer	2.82e-05	0.000237	CcSEcCtD
Dinoprostone—Tachycardia—Prednisone—hematologic cancer	2.8e-05	0.000235	CcSEcCtD
Dinoprostone—Nausea—Gemcitabine—hematologic cancer	2.78e-05	0.000234	CcSEcCtD
Dinoprostone—Vomiting—Cisplatin—hematologic cancer	2.78e-05	0.000233	CcSEcCtD
Dinoprostone—Hyperhidrosis—Prednisone—hematologic cancer	2.77e-05	0.000233	CcSEcCtD
Dinoprostone—Vision blurred—Methotrexate—hematologic cancer	2.77e-05	0.000232	CcSEcCtD
Dinoprostone—Rash—Cisplatin—hematologic cancer	2.75e-05	0.000231	CcSEcCtD
Dinoprostone—Dermatitis—Cisplatin—hematologic cancer	2.75e-05	0.000231	CcSEcCtD
Dinoprostone—Diarrhoea—Etoposide—hematologic cancer	2.74e-05	0.00023	CcSEcCtD
Dinoprostone—Flushing—Doxorubicin—hematologic cancer	2.71e-05	0.000228	CcSEcCtD
Dinoprostone—Tension—Epirubicin—hematologic cancer	2.7e-05	0.000227	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.69e-05	0.000226	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.69e-05	0.000226	CcSEcCtD
Dinoprostone—Hypersensitivity—Triamcinolone—hematologic cancer	2.67e-05	0.000225	CcSEcCtD
Dinoprostone—Back pain—Epirubicin—hematologic cancer	2.66e-05	0.000223	CcSEcCtD
Dinoprostone—Angiopathy—Doxorubicin—hematologic cancer	2.65e-05	0.000223	CcSEcCtD
Dinoprostone—Dizziness—Etoposide—hematologic cancer	2.65e-05	0.000222	CcSEcCtD
Dinoprostone—Muscle spasms—Epirubicin—hematologic cancer	2.64e-05	0.000222	CcSEcCtD
Dinoprostone—Immune system disorder—Doxorubicin—hematologic cancer	2.64e-05	0.000222	CcSEcCtD
Dinoprostone—Chills—Doxorubicin—hematologic cancer	2.62e-05	0.00022	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.61e-05	0.000219	CcSEcCtD
Dinoprostone—Dizziness—Prednisolone—hematologic cancer	2.61e-05	0.000219	CcSEcCtD
Dinoprostone—Arrhythmia—Doxorubicin—hematologic cancer	2.61e-05	0.000219	CcSEcCtD
Dinoprostone—Asthenia—Triamcinolone—hematologic cancer	2.6e-05	0.000219	CcSEcCtD
Dinoprostone—Body temperature increased—Dexamethasone—hematologic cancer	2.6e-05	0.000219	CcSEcCtD
Dinoprostone—Abdominal pain—Dexamethasone—hematologic cancer	2.6e-05	0.000219	CcSEcCtD
Dinoprostone—Body temperature increased—Betamethasone—hematologic cancer	2.6e-05	0.000219	CcSEcCtD
Dinoprostone—Abdominal pain—Betamethasone—hematologic cancer	2.6e-05	0.000219	CcSEcCtD
Dinoprostone—Nausea—Cisplatin—hematologic cancer	2.6e-05	0.000218	CcSEcCtD
Dinoprostone—Vision blurred—Epirubicin—hematologic cancer	2.59e-05	0.000218	CcSEcCtD
Dinoprostone—Paraesthesia—Prednisone—hematologic cancer	2.58e-05	0.000216	CcSEcCtD
Dinoprostone—Cough—Methotrexate—hematologic cancer	2.56e-05	0.000215	CcSEcCtD
Dinoprostone—Vomiting—Etoposide—hematologic cancer	2.54e-05	0.000214	CcSEcCtD
Dinoprostone—Rash—Etoposide—hematologic cancer	2.52e-05	0.000212	CcSEcCtD
Dinoprostone—Dermatitis—Etoposide—hematologic cancer	2.52e-05	0.000212	CcSEcCtD
Dinoprostone—Headache—Etoposide—hematologic cancer	2.51e-05	0.000211	CcSEcCtD
Dinoprostone—Chest pain—Methotrexate—hematologic cancer	2.5e-05	0.00021	CcSEcCtD
Dinoprostone—Myalgia—Methotrexate—hematologic cancer	2.5e-05	0.00021	CcSEcCtD
Dinoprostone—Arthralgia—Methotrexate—hematologic cancer	2.5e-05	0.00021	CcSEcCtD
Dinoprostone—Tension—Doxorubicin—hematologic cancer	2.5e-05	0.00021	CcSEcCtD
Dinoprostone—Rash—Prednisolone—hematologic cancer	2.49e-05	0.000209	CcSEcCtD
Dinoprostone—Dermatitis—Prednisolone—hematologic cancer	2.49e-05	0.000209	CcSEcCtD
Dinoprostone—Headache—Prednisolone—hematologic cancer	2.47e-05	0.000208	CcSEcCtD
Dinoprostone—Syncope—Epirubicin—hematologic cancer	2.47e-05	0.000207	CcSEcCtD
Dinoprostone—Back pain—Doxorubicin—hematologic cancer	2.46e-05	0.000207	CcSEcCtD
Dinoprostone—Muscle spasms—Doxorubicin—hematologic cancer	2.45e-05	0.000205	CcSEcCtD
Dinoprostone—Loss of consciousness—Epirubicin—hematologic cancer	2.42e-05	0.000203	CcSEcCtD
Dinoprostone—Dizziness—Triamcinolone—hematologic cancer	2.4e-05	0.000202	CcSEcCtD
Dinoprostone—Cough—Epirubicin—hematologic cancer	2.4e-05	0.000201	CcSEcCtD
Dinoprostone—Anaphylactic shock—Methotrexate—hematologic cancer	2.4e-05	0.000201	CcSEcCtD
Dinoprostone—Vision blurred—Doxorubicin—hematologic cancer	2.4e-05	0.000201	CcSEcCtD
Dinoprostone—Nausea—Etoposide—hematologic cancer	2.38e-05	0.0002	CcSEcCtD
Dinoprostone—Hypertension—Epirubicin—hematologic cancer	2.37e-05	0.000199	CcSEcCtD
Dinoprostone—Asthenia—Betamethasone—hematologic cancer	2.36e-05	0.000198	CcSEcCtD
Dinoprostone—Asthenia—Dexamethasone—hematologic cancer	2.36e-05	0.000198	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Prednisone—hematologic cancer	2.35e-05	0.000197	CcSEcCtD
Dinoprostone—Nausea—Prednisolone—hematologic cancer	2.35e-05	0.000197	CcSEcCtD
Dinoprostone—Chest pain—Epirubicin—hematologic cancer	2.34e-05	0.000197	CcSEcCtD
Dinoprostone—Myalgia—Epirubicin—hematologic cancer	2.34e-05	0.000197	CcSEcCtD
Dinoprostone—Arthralgia—Epirubicin—hematologic cancer	2.34e-05	0.000197	CcSEcCtD
Dinoprostone—Hyperhidrosis—Methotrexate—hematologic cancer	2.32e-05	0.000195	CcSEcCtD
Dinoprostone—Vomiting—Triamcinolone—hematologic cancer	2.31e-05	0.000194	CcSEcCtD
Dinoprostone—Rash—Triamcinolone—hematologic cancer	2.29e-05	0.000192	CcSEcCtD
Dinoprostone—Dermatitis—Triamcinolone—hematologic cancer	2.29e-05	0.000192	CcSEcCtD
Dinoprostone—Syncope—Doxorubicin—hematologic cancer	2.28e-05	0.000192	CcSEcCtD
Dinoprostone—Headache—Triamcinolone—hematologic cancer	2.27e-05	0.000191	CcSEcCtD
Dinoprostone—Abdominal pain—Prednisone—hematologic cancer	2.27e-05	0.00019	CcSEcCtD
Dinoprostone—Body temperature increased—Prednisone—hematologic cancer	2.27e-05	0.00019	CcSEcCtD
Dinoprostone—Diarrhoea—Dexamethasone—hematologic cancer	2.25e-05	0.000189	CcSEcCtD
Dinoprostone—Diarrhoea—Betamethasone—hematologic cancer	2.25e-05	0.000189	CcSEcCtD
Dinoprostone—Anaphylactic shock—Epirubicin—hematologic cancer	2.24e-05	0.000188	CcSEcCtD
Dinoprostone—Hypotension—Methotrexate—hematologic cancer	2.24e-05	0.000188	CcSEcCtD
Dinoprostone—Loss of consciousness—Doxorubicin—hematologic cancer	2.24e-05	0.000188	CcSEcCtD
Dinoprostone—Cough—Doxorubicin—hematologic cancer	2.22e-05	0.000186	CcSEcCtD
Dinoprostone—Shock—Epirubicin—hematologic cancer	2.21e-05	0.000185	CcSEcCtD
Dinoprostone—Hypertension—Doxorubicin—hematologic cancer	2.2e-05	0.000184	CcSEcCtD
Dinoprostone—Tachycardia—Epirubicin—hematologic cancer	2.19e-05	0.000184	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.18e-05	0.000183	CcSEcCtD
Dinoprostone—Dizziness—Dexamethasone—hematologic cancer	2.18e-05	0.000183	CcSEcCtD
Dinoprostone—Dizziness—Betamethasone—hematologic cancer	2.18e-05	0.000183	CcSEcCtD
Dinoprostone—Hyperhidrosis—Epirubicin—hematologic cancer	2.17e-05	0.000182	CcSEcCtD
Dinoprostone—Myalgia—Doxorubicin—hematologic cancer	2.17e-05	0.000182	CcSEcCtD
Dinoprostone—Arthralgia—Doxorubicin—hematologic cancer	2.17e-05	0.000182	CcSEcCtD
Dinoprostone—Chest pain—Doxorubicin—hematologic cancer	2.17e-05	0.000182	CcSEcCtD
Dinoprostone—Nausea—Triamcinolone—hematologic cancer	2.16e-05	0.000181	CcSEcCtD
Dinoprostone—Paraesthesia—Methotrexate—hematologic cancer	2.15e-05	0.000181	CcSEcCtD
Dinoprostone—Dyspnoea—Methotrexate—hematologic cancer	2.14e-05	0.000179	CcSEcCtD
Dinoprostone—Hypersensitivity—Prednisone—hematologic cancer	2.11e-05	0.000177	CcSEcCtD
Dinoprostone—Hypotension—Epirubicin—hematologic cancer	2.1e-05	0.000176	CcSEcCtD
Dinoprostone—Vomiting—Dexamethasone—hematologic cancer	2.09e-05	0.000176	CcSEcCtD
Dinoprostone—Vomiting—Betamethasone—hematologic cancer	2.09e-05	0.000176	CcSEcCtD
Dinoprostone—Rash—Betamethasone—hematologic cancer	2.08e-05	0.000174	CcSEcCtD
Dinoprostone—Rash—Dexamethasone—hematologic cancer	2.08e-05	0.000174	CcSEcCtD
Dinoprostone—Anaphylactic shock—Doxorubicin—hematologic cancer	2.08e-05	0.000174	CcSEcCtD
Dinoprostone—Dermatitis—Dexamethasone—hematologic cancer	2.08e-05	0.000174	CcSEcCtD
Dinoprostone—Dermatitis—Betamethasone—hematologic cancer	2.08e-05	0.000174	CcSEcCtD
Dinoprostone—Headache—Dexamethasone—hematologic cancer	2.06e-05	0.000173	CcSEcCtD
Dinoprostone—Headache—Betamethasone—hematologic cancer	2.06e-05	0.000173	CcSEcCtD
Dinoprostone—Asthenia—Prednisone—hematologic cancer	2.06e-05	0.000173	CcSEcCtD
Dinoprostone—Pain—Methotrexate—hematologic cancer	2.05e-05	0.000172	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	2.04e-05	0.000172	CcSEcCtD
Dinoprostone—Shock—Doxorubicin—hematologic cancer	2.04e-05	0.000171	CcSEcCtD
Dinoprostone—Tachycardia—Doxorubicin—hematologic cancer	2.03e-05	0.00017	CcSEcCtD
Dinoprostone—Paraesthesia—Epirubicin—hematologic cancer	2.01e-05	0.000169	CcSEcCtD
Dinoprostone—Hyperhidrosis—Doxorubicin—hematologic cancer	2.01e-05	0.000169	CcSEcCtD
Dinoprostone—Dyspnoea—Epirubicin—hematologic cancer	2e-05	0.000168	CcSEcCtD
Dinoprostone—Diarrhoea—Prednisone—hematologic cancer	1.96e-05	0.000165	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.96e-05	0.000165	CcSEcCtD
Dinoprostone—Nausea—Dexamethasone—hematologic cancer	1.96e-05	0.000164	CcSEcCtD
Dinoprostone—Nausea—Betamethasone—hematologic cancer	1.96e-05	0.000164	CcSEcCtD
Dinoprostone—Hypotension—Doxorubicin—hematologic cancer	1.94e-05	0.000163	CcSEcCtD
Dinoprostone—Pain—Epirubicin—hematologic cancer	1.92e-05	0.000161	CcSEcCtD
Dinoprostone—Dizziness—Prednisone—hematologic cancer	1.9e-05	0.000159	CcSEcCtD
Dinoprostone—Body temperature increased—Methotrexate—hematologic cancer	1.9e-05	0.000159	CcSEcCtD
Dinoprostone—Abdominal pain—Methotrexate—hematologic cancer	1.9e-05	0.000159	CcSEcCtD
Dinoprostone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.89e-05	0.000159	CcSEcCtD
Dinoprostone—Paraesthesia—Doxorubicin—hematologic cancer	1.86e-05	0.000157	CcSEcCtD
Dinoprostone—Dyspnoea—Doxorubicin—hematologic cancer	1.85e-05	0.000155	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.83e-05	0.000154	CcSEcCtD
Dinoprostone—Vomiting—Prednisone—hematologic cancer	1.82e-05	0.000153	CcSEcCtD
Dinoprostone—Rash—Prednisone—hematologic cancer	1.81e-05	0.000152	CcSEcCtD
Dinoprostone—Dermatitis—Prednisone—hematologic cancer	1.81e-05	0.000152	CcSEcCtD
Dinoprostone—Headache—Prednisone—hematologic cancer	1.8e-05	0.000151	CcSEcCtD
Dinoprostone—Pain—Doxorubicin—hematologic cancer	1.78e-05	0.000149	CcSEcCtD
Dinoprostone—Abdominal pain—Epirubicin—hematologic cancer	1.77e-05	0.000149	CcSEcCtD
Dinoprostone—Body temperature increased—Epirubicin—hematologic cancer	1.77e-05	0.000149	CcSEcCtD
Dinoprostone—Hypersensitivity—Methotrexate—hematologic cancer	1.77e-05	0.000148	CcSEcCtD
Dinoprostone—Asthenia—Methotrexate—hematologic cancer	1.72e-05	0.000144	CcSEcCtD
Dinoprostone—Nausea—Prednisone—hematologic cancer	1.7e-05	0.000143	CcSEcCtD
Dinoprostone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.7e-05	0.000143	CcSEcCtD
Dinoprostone—Hypersensitivity—Epirubicin—hematologic cancer	1.65e-05	0.000139	CcSEcCtD
Dinoprostone—Abdominal pain—Doxorubicin—hematologic cancer	1.64e-05	0.000138	CcSEcCtD
Dinoprostone—Body temperature increased—Doxorubicin—hematologic cancer	1.64e-05	0.000138	CcSEcCtD
Dinoprostone—Diarrhoea—Methotrexate—hematologic cancer	1.64e-05	0.000138	CcSEcCtD
Dinoprostone—Asthenia—Epirubicin—hematologic cancer	1.61e-05	0.000135	CcSEcCtD
Dinoprostone—Dizziness—Methotrexate—hematologic cancer	1.59e-05	0.000133	CcSEcCtD
Dinoprostone—Diarrhoea—Epirubicin—hematologic cancer	1.54e-05	0.000129	CcSEcCtD
Dinoprostone—Hypersensitivity—Doxorubicin—hematologic cancer	1.53e-05	0.000128	CcSEcCtD
Dinoprostone—Vomiting—Methotrexate—hematologic cancer	1.52e-05	0.000128	CcSEcCtD
Dinoprostone—Rash—Methotrexate—hematologic cancer	1.51e-05	0.000127	CcSEcCtD
Dinoprostone—Dermatitis—Methotrexate—hematologic cancer	1.51e-05	0.000127	CcSEcCtD
Dinoprostone—Headache—Methotrexate—hematologic cancer	1.5e-05	0.000126	CcSEcCtD
Dinoprostone—Asthenia—Doxorubicin—hematologic cancer	1.49e-05	0.000125	CcSEcCtD
Dinoprostone—Dizziness—Epirubicin—hematologic cancer	1.48e-05	0.000125	CcSEcCtD
Dinoprostone—Vomiting—Epirubicin—hematologic cancer	1.43e-05	0.00012	CcSEcCtD
Dinoprostone—Nausea—Methotrexate—hematologic cancer	1.42e-05	0.00012	CcSEcCtD
Dinoprostone—Diarrhoea—Doxorubicin—hematologic cancer	1.42e-05	0.000119	CcSEcCtD
Dinoprostone—Rash—Epirubicin—hematologic cancer	1.41e-05	0.000119	CcSEcCtD
Dinoprostone—Dermatitis—Epirubicin—hematologic cancer	1.41e-05	0.000119	CcSEcCtD
Dinoprostone—Headache—Epirubicin—hematologic cancer	1.41e-05	0.000118	CcSEcCtD
Dinoprostone—Dizziness—Doxorubicin—hematologic cancer	1.37e-05	0.000115	CcSEcCtD
Dinoprostone—Nausea—Epirubicin—hematologic cancer	1.33e-05	0.000112	CcSEcCtD
Dinoprostone—Vomiting—Doxorubicin—hematologic cancer	1.32e-05	0.000111	CcSEcCtD
Dinoprostone—Rash—Doxorubicin—hematologic cancer	1.31e-05	0.00011	CcSEcCtD
Dinoprostone—Dermatitis—Doxorubicin—hematologic cancer	1.31e-05	0.00011	CcSEcCtD
Dinoprostone—Headache—Doxorubicin—hematologic cancer	1.3e-05	0.000109	CcSEcCtD
Dinoprostone—Nausea—Doxorubicin—hematologic cancer	1.23e-05	0.000104	CcSEcCtD
Dinoprostone—PTGFR—Signaling Pathways—MTOR—hematologic cancer	2.13e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CB—hematologic cancer	2.13e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—ALB—hematologic cancer	2.12e-06	2.17e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—HRAS—hematologic cancer	2.12e-06	2.16e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—FHL2—hematologic cancer	2.12e-06	2.16e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—EP300—hematologic cancer	2.11e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MAPK3—hematologic cancer	2.1e-06	2.15e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CB—hematologic cancer	2.08e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CB—hematologic cancer	2.08e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MTOR—hematologic cancer	2.08e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MTOR—hematologic cancer	2.08e-06	2.13e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AGRN—hematologic cancer	2.07e-06	2.12e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—GSTM1—hematologic cancer	2.07e-06	2.11e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—NCOR1—hematologic cancer	2.07e-06	2.11e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—HRAS—hematologic cancer	2.07e-06	2.11e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTP1—hematologic cancer	2.06e-06	2.11e-05	CbGpPWpGaD
Dinoprostone—HPGDS—Metabolism—AKT1—hematologic cancer	2.06e-06	2.1e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—SRC—hematologic cancer	2.05e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—KRAS—hematologic cancer	2.05e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—MYC—hematologic cancer	2.04e-06	2.09e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TGFB1—hematologic cancer	2.04e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3R1—hematologic cancer	2.03e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—HRAS—hematologic cancer	2.03e-06	2.08e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—IL6—hematologic cancer	2.03e-06	2.07e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1B—hematologic cancer	2e-06	2.04e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—HRAS—hematologic cancer	1.99e-06	2.03e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—HRAS—hematologic cancer	1.99e-06	2.03e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—STAT3—hematologic cancer	1.98e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—PTGFR—GPCR downstream signaling—AKT1—hematologic cancer	1.98e-06	2.02e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—NRAS—hematologic cancer	1.97e-06	2.01e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HMMR—hematologic cancer	1.97e-06	2.01e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—IDH2—hematologic cancer	1.97e-06	2.01e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CASP3—hematologic cancer	1.96e-06	2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1B—hematologic cancer	1.95e-06	2e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1B—hematologic cancer	1.95e-06	2e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL2—hematologic cancer	1.95e-06	2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ABCB1—hematologic cancer	1.95e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—IL6—hematologic cancer	1.94e-06	1.99e-05	CbGpPWpGaD
Dinoprostone—PTGER1—GPCR downstream signaling—AKT1—hematologic cancer	1.93e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—PTGIR—GPCR downstream signaling—AKT1—hematologic cancer	1.93e-06	1.98e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—MTHFR—hematologic cancer	1.93e-06	1.97e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTP1—hematologic cancer	1.92e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CASP3—hematologic cancer	1.92e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CASP3—hematologic cancer	1.92e-06	1.96e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL2—hematologic cancer	1.91e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL2—hematologic cancer	1.91e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CCND1—hematologic cancer	1.9e-06	1.95e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—IL6—hematologic cancer	1.9e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—IL6—hematologic cancer	1.9e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—JUN—hematologic cancer	1.9e-06	1.94e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—NCOR1—hematologic cancer	1.89e-06	1.93e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—GSTM1—hematologic cancer	1.89e-06	1.93e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MAPK3—hematologic cancer	1.89e-06	1.93e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—KRAS—hematologic cancer	1.89e-06	1.93e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.88e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—PIK3CA—hematologic cancer	1.88e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CB—hematologic cancer	1.88e-06	1.92e-05	CbGpPWpGaD
Dinoprostone—PTGER4—Signaling Pathways—AKT1—hematologic cancer	1.87e-06	1.91e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CCND1—hematologic cancer	1.86e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CCND1—hematologic cancer	1.86e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—JUN—hematologic cancer	1.86e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—JUN—hematologic cancer	1.86e-06	1.9e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PTEN—hematologic cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ARNTL—hematologic cancer	1.85e-06	1.89e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—CDKN1A—hematologic cancer	1.84e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PTEN—hematologic cancer	1.84e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—MYC—hematologic cancer	1.84e-06	1.88e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—TGFB1—hematologic cancer	1.83e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—MTHFR—hematologic cancer	1.83e-06	1.87e-05	CbGpPWpGaD
Dinoprostone—ABCC4—Hemostasis—AKT1—hematologic cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—TP53—hematologic cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ABCB1—hematologic cancer	1.82e-06	1.86e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—CDKN1A—hematologic cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—CDKN1A—hematologic cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PTEN—hematologic cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PTEN—hematologic cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ACP5—hematologic cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CA9—hematologic cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK8—hematologic cancer	1.8e-06	1.84e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CG—hematologic cancer	1.79e-06	1.83e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling by GPCR—AKT1—hematologic cancer	1.79e-06	1.83e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOR2—hematologic cancer	1.78e-06	1.81e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—GSTM1—hematologic cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—NCOR1—hematologic cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—EP300—hematologic cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK8—hematologic cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK8—hematologic cancer	1.76e-06	1.8e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling by GPCR—AKT1—hematologic cancer	1.76e-06	1.79e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling by GPCR—AKT1—hematologic cancer	1.76e-06	1.79e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—EP300—hematologic cancer	1.75e-06	1.79e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—HRAS—hematologic cancer	1.74e-06	1.78e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—PIK3CA—hematologic cancer	1.73e-06	1.77e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—EP300—hematologic cancer	1.72e-06	1.75e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—EP300—hematologic cancer	1.72e-06	1.75e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—SRC—hematologic cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.7e-06	1.74e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—KRAS—hematologic cancer	1.7e-06	1.73e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—IDH1—hematologic cancer	1.69e-06	1.73e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—TP53—hematologic cancer	1.68e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—MTHFR—hematologic cancer	1.67e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTO1—hematologic cancer	1.67e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCC3—hematologic cancer	1.67e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—TXN—hematologic cancer	1.67e-06	1.71e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—SRC—hematologic cancer	1.67e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—SRC—hematologic cancer	1.67e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—IL6—hematologic cancer	1.66e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—CREBBP—hematologic cancer	1.66e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—VEGFA—hematologic cancer	1.66e-06	1.7e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—STAT3—hematologic cancer	1.64e-06	1.68e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—NRAS—hematologic cancer	1.64e-06	1.68e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SPHK1—hematologic cancer	1.64e-06	1.67e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—VEGFA—hematologic cancer	1.63e-06	1.66e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—VEGFA—hematologic cancer	1.63e-06	1.66e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CG—hematologic cancer	1.62e-06	1.66e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PTEN—hematologic cancer	1.62e-06	1.66e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—STAT3—hematologic cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—STAT3—hematologic cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—NRAS—hematologic cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—NRAS—hematologic cancer	1.61e-06	1.64e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—HRAS—hematologic cancer	1.6e-06	1.64e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CD—hematologic cancer	1.58e-06	1.61e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—UGT1A1—hematologic cancer	1.57e-06	1.61e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MAPK3—hematologic cancer	1.57e-06	1.6e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—MTHFR—hematologic cancer	1.56e-06	1.59e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—PIK3CA—hematologic cancer	1.56e-06	1.59e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—ALB—hematologic cancer	1.56e-06	1.59e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—EP300—hematologic cancer	1.55e-06	1.58e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MAPK3—hematologic cancer	1.54e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MAPK3—hematologic cancer	1.54e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—IL6—hematologic cancer	1.54e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—PTGER2—Signaling Pathways—AKT1—hematologic cancer	1.54e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	1.53e-06	1.57e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SLC22A1—hematologic cancer	1.53e-06	1.56e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CRABP1—hematologic cancer	1.53e-06	1.56e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—MYC—hematologic cancer	1.53e-06	1.56e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TGFB1—hematologic cancer	1.52e-06	1.56e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—CREBBP—hematologic cancer	1.5e-06	1.54e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—MYC—hematologic cancer	1.5e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—MYC—hematologic cancer	1.5e-06	1.53e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TGFB1—hematologic cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TGFB1—hematologic cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALOX5—hematologic cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3R1—hematologic cancer	1.49e-06	1.52e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NUP98—hematologic cancer	1.44e-06	1.47e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—HRAS—hematologic cancer	1.44e-06	1.47e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CD—hematologic cancer	1.43e-06	1.46e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—CREBBP—hematologic cancer	1.42e-06	1.45e-05	CbGpPWpGaD
Dinoprostone—PTGER3—Signaling Pathways—AKT1—hematologic cancer	1.42e-06	1.45e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—KRAS—hematologic cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—ALB—hematologic cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CG—hematologic cancer	1.41e-06	1.44e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ADCY7—hematologic cancer	1.4e-06	1.43e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOA3—hematologic cancer	1.4e-06	1.43e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NUP214—hematologic cancer	1.39e-06	1.42e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—KRAS—hematologic cancer	1.38e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—KRAS—hematologic cancer	1.38e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—IL6—hematologic cancer	1.38e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.38e-06	1.41e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CB—hematologic cancer	1.37e-06	1.4e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCG2—hematologic cancer	1.36e-06	1.39e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTR—hematologic cancer	1.36e-06	1.39e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	1.35e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3R1—hematologic cancer	1.35e-06	1.38e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ENO2—hematologic cancer	1.34e-06	1.37e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—ALB—hematologic cancer	1.33e-06	1.36e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CG—hematologic cancer	1.31e-06	1.34e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—PIK3CA—hematologic cancer	1.31e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—CREBBP—hematologic cancer	1.3e-06	1.33e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—PIK3CA—hematologic cancer	1.3e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTT1—hematologic cancer	1.3e-06	1.32e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.28e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	1.27e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Disease—AKT1—hematologic cancer	1.27e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—PIK3CA—hematologic cancer	1.27e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—PIK3CA—hematologic cancer	1.27e-06	1.3e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—SDC1—hematologic cancer	1.27e-06	1.29e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—TP53—hematologic cancer	1.25e-06	1.28e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CB—hematologic cancer	1.24e-06	1.27e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CD—hematologic cancer	1.24e-06	1.26e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—TP53—hematologic cancer	1.23e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—TP53—hematologic cancer	1.23e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—ALB—hematologic cancer	1.22e-06	1.25e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—CREBBP—hematologic cancer	1.22e-06	1.24e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.21e-06	1.24e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—HRAS—hematologic cancer	1.2e-06	1.23e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.19e-06	1.22e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PTEN—hematologic cancer	1.19e-06	1.21e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.18e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—HRAS—hematologic cancer	1.17e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—HRAS—hematologic cancer	1.17e-06	1.2e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3R1—hematologic cancer	1.17e-06	1.19e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CD—hematologic cancer	1.15e-06	1.18e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—IL6—hematologic cancer	1.15e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—PIK3CA—hematologic cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.14e-06	1.17e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—ALB—hematologic cancer	1.14e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—EP300—hematologic cancer	1.13e-06	1.16e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—IL6—hematologic cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—IL6—hematologic cancer	1.12e-06	1.15e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3R1—hematologic cancer	1.09e-06	1.11e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CD44—hematologic cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NQO1—hematologic cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CB—hematologic cancer	1.08e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PTEN—hematologic cancer	1.07e-06	1.1e-05	CbGpPWpGaD
Dinoprostone—ABCC5—Metabolism—AKT1—hematologic cancer	1.07e-06	1.09e-05	CbGpPWpGaD
Dinoprostone—PTGFR—Signaling Pathways—AKT1—hematologic cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.06e-06	1.08e-05	CbGpPWpGaD
Dinoprostone—PTGER1—Signaling Pathways—AKT1—hematologic cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—PTGIR—Signaling Pathways—AKT1—hematologic cancer	1.04e-06	1.06e-05	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—EP300—hematologic cancer	1.02e-06	1.05e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CYCS—hematologic cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.02e-06	1.04e-05	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	1.01e-06	1.03e-05	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CB—hematologic cancer	1e-06	1.03e-05	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—EP300—hematologic cancer	9.69e-07	9.9e-06	CbGpPWpGaD
Dinoprostone—CYP11A1—Metabolism—AKT1—hematologic cancer	9.34e-07	9.54e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PTEN—hematologic cancer	9.31e-07	9.51e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	9.12e-07	9.31e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTP1—hematologic cancer	8.99e-07	9.18e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—EP300—hematologic cancer	8.88e-07	9.07e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	8.69e-07	8.88e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PTEN—hematologic cancer	8.68e-07	8.86e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ABCB1—hematologic cancer	8.51e-07	8.69e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—PIK3CA—hematologic cancer	8.38e-07	8.56e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—EP300—hematologic cancer	8.28e-07	8.45e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—GSTM1—hematologic cancer	8.26e-07	8.44e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—NCOR1—hematologic cancer	8.26e-07	8.44e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—PIK3CA—hematologic cancer	7.57e-07	7.74e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—MTHFR—hematologic cancer	7.3e-07	7.46e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	7.17e-07	7.32e-06	CbGpPWpGaD
Dinoprostone—SLCO1A2—Metabolism—AKT1—hematologic cancer	6.85e-07	6.99e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—PIK3CA—hematologic cancer	6.57e-07	6.71e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.43e-07	6.57e-06	CbGpPWpGaD
Dinoprostone—CYP19A1—Metabolism—AKT1—hematologic cancer	6.19e-07	6.32e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CG—hematologic cancer	6.13e-07	6.26e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—PIK3CA—hematologic cancer	6.12e-07	6.25e-06	CbGpPWpGaD
Dinoprostone—SLCO1B1—Metabolism—AKT1—hematologic cancer	5.85e-07	5.98e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—CREBBP—hematologic cancer	5.69e-07	5.81e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CD—hematologic cancer	5.39e-07	5.51e-06	CbGpPWpGaD
Dinoprostone—SLC22A2—Metabolism—AKT1—hematologic cancer	5.37e-07	5.48e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—ALB—hematologic cancer	5.32e-07	5.44e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3R1—hematologic cancer	5.09e-07	5.2e-06	CbGpPWpGaD
Dinoprostone—SLC22A1—Metabolism—AKT1—hematologic cancer	5e-07	5.11e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CB—hematologic cancer	4.7e-07	4.8e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PTEN—hematologic cancer	4.06e-07	4.15e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—EP300—hematologic cancer	3.87e-07	3.96e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—PIK3CA—hematologic cancer	2.86e-07	2.93e-06	CbGpPWpGaD
Dinoprostone—CYP1A2—Metabolism—AKT1—hematologic cancer	2.34e-07	2.39e-06	CbGpPWpGaD
